Skip to main content

Advertisement

Log in

Thyroid Cancer Detection with Dual-isotope Parathyroid Scintigraphy in Primary Hyperparathyroidism

  • Endocrine Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Thyroid cancer cells have been shown to take up 99mTc-sestamibi. The role for 99mTc-sestamibi scintigraphy (Tc-MIBI) in the diagnosis of thyroid cancer in patients with primary hyperparathyroidism (PHPT) is unclear. Our aim was to determine whether dual-isotope parathyroid scintigraphy is useful in identifying thyroid cancer.

Methods

A prospective database of 3,187 patients who underwent neck exploration for PHPT was reviewed to identify patients who had concurrent thyroid resection. Patients with benign and malignant thyroid disease were comparatively analyzed.

Results

A total of 470 patients underwent both thyroidectomy and parathyroidectomy (reoperations in 21%). Benign disease (n = 391, 83%) was more common than malignancy [papillary thyroid cancer (n = 75) and medullary thyroid cancer (n = 5); 1 had both]. Dual-isotope scintigraphy obtained in 374 patients (80%) had a sensitivity of 67% and a positive predictive value of 66% for parathyroid adenoma localization in these patients with thyroid disease. False-positive scintigraphy occurred in 22% with benign and 45% with malignant thyroid disease (P = 0.002). On Tc-MIBI imaging, 54 (86%) of 63 patients with malignancy had hot nodules, compared to 248 (81%) of 308 patients with benign disease (P = 0.49). On I-123 imaging, 34 (54%) of 63 patients with malignancy had cold nodules, compared to 42 (14%) of 304 patients with benign disease (P < 0.001). A dual-isotype phenotype of both Tc-MIBI-Hot and I-123-Cold had sensitivity 52%, specificity 88%, positive predictive value 47%, and negative predictive value 90% for detecting a thyroid malignancy.

Conclusions

A Tc-MIBI-Hot/I-123-Cold phenotype is very specific for detecting thyroid malignancy. Patients with this imaging phenotype should strongly be considered for preoperative ultrasound-guided biopsy. Patients found intraoperatively to have false-positive parathyroid scintigraphy should be evaluated for thyroid cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Sarkar SD, Afriyie MO, Palestro CJ. Recombinant human thyroid-stimulating hormone–aided scintigraphy: comparison of imaging at multiple times after I-131 administration. Clin Nucl Med. 2001;26:392–5.

    Article  PubMed  CAS  Google Scholar 

  2. Beus KS, Stack BC Jr. Synchronous thyroid pathology in patients presenting with primary hyperparathyroidism. Am J Otolaryngol. 2004;25:308–12.

    Article  PubMed  Google Scholar 

  3. Leitha T, Staudenherz A. Concomitant hyperparathyroidism and nonmedullary thyroid cancer, with a review of the literature. Clin Nucl Med. 2003;28:113–7.

    PubMed  Google Scholar 

  4. Chang MC, Tsai SC, Lin WY. Dual-phase 99mTc-MIBI parathyroid imaging reveals synchronous parathyroid adenoma and papillary thyroid carcinoma: a case report. Kaohsiung J Med Sci. 2008;24:542–7.

    Article  PubMed  Google Scholar 

  5. Tomas MB, Tronco GG, Karayalcin G, Palestro CJ. FDG uptake in infectious mononucleosis. Clin Positron Imaging. 2000;3:176.

    Article  PubMed  Google Scholar 

  6. Love C, Pugliese PV, Afriyie MO, Tomas MB, Marwin SE, Palestro CJ. Utility of F-18 FDG imaging for diagnosing the infected joint replacement. Clin Positron Imaging. 2000;3:159.

    Article  PubMed  Google Scholar 

  7. Love C, Patel M, Lonner BS, Tomas MB, Palestro CJ. Diagnosing spinal osteomyelitis: a comparison of bone and Ga-67 scintigraphy and magnetic resonance imaging. Clin Nucl Med. 2000;25:963–77.

    Article  PubMed  CAS  Google Scholar 

  8. Palestro CJ, Weiland FL, Seabold JE, et al. Localizing infection with a technetium-99m-labeled peptide: initial results. Nucl Med Commun. 2001;22:695–701.

    Article  PubMed  CAS  Google Scholar 

  9. Masatsugu T, Yamashita H, Noguchi S, et al. Thyroid evaluation in patients with primary hyperparathyroidism. Endocr J. 2005;52:177–82.

    Article  PubMed  Google Scholar 

  10. Palestro CJ, Tomas MB, Tronco GG. Radionuclide imaging of the parathyroid glands. Semin Nucl Med. 2005;35:266–76.

    Article  PubMed  Google Scholar 

  11. Wakamatsu H, Noguchi S, Yamashita H, et al. Parathyroid scintigraphy with 99mTc-MIBI and 123I subtraction: a comparison with magnetic resonance imaging and ultrasonography. Nucl Med Commun. 2003;24:755–62.

    Article  PubMed  CAS  Google Scholar 

  12. Kusakabe K, Oshima M, Takami H, Murata H, Aburano T, Kubo A. [Evaluation of clinical utility of 99mTc-MIBI scintigraphy in the localization of hyperfunctioning parathyroid lesions in patients with hyperparathyroidism—a report of multicenter phase III clinical trials]. Kaku Igaku. 1998;35:887–99.

    PubMed  CAS  Google Scholar 

  13. Sarikaya A, Huseyinova G, Irfanoğlu ME, Erkmen N, Cermik TF, Berkarda S. The relationship between 99Tc(m)-sestamibi uptake and ultrastructural cell types of thyroid tumours. Nucl Med Commun. 2001;22:39–44.

    Article  PubMed  CAS  Google Scholar 

  14. Bentrem DJ, Angelos P, Talamonti MS, Nayar R. Is preoperative investigation of the thyroid justified in patients undergoing parathyroidectomy for hyperparathyroidism? Thyroid. 2002;12:1109–12.

    Article  PubMed  Google Scholar 

  15. Pickard AL, Gridley G, Mellemkjae L, et al. Hyperparathyroidism and subsequent cancer risk in Denmark. Cancer. 2002;95:1611–7.

    Article  PubMed  Google Scholar 

  16. LiVolsi VA, Feind CR. Parathyroid adenoma and nonmedullary thyroid carcinoma. Cancer. 1976;38:1391–3.

    Article  PubMed  CAS  Google Scholar 

  17. Fathizadeh A, Fretzin DF, Favus MJ, Coe FL. Primary hyperparathyroidism and basal cell nevus syndrome. Ann Intern Med. 1980;93:147.

    PubMed  CAS  Google Scholar 

  18. Burmeister LA, Sandberg M, Carty SE, Watson CG. Thyroid carcinoma found at parathyroidectomy: association with primary, secondary, and tertiary hyperparathyroidism. Cancer. 1997;79:1611–6.

    Article  PubMed  CAS  Google Scholar 

  19. Milas M, Mensah A, Alghoul M, et al. The impact of office neck ultrasonography on reducing unnecessary thyroid surgery in patients undergoing parathyroidectomy. Thyroid. 2005;15:1055–9.

    Article  PubMed  Google Scholar 

  20. Wilhelm SM. Utility of I-123 thyroid uptake scan in incidental thyroid nodules: an old test with a new role. Surgery. 2008;144:511–5.

    Article  PubMed  Google Scholar 

  21. Beristain Hernández JL, Servín Torres E, Sosa Caballero A, et al. Determination of the diagnostic accuracy of 99mTc sestamibi scanning in patients with thyroid nodule and a definitive histopathological report. Endocrinol Nutr. 2010;57:460–6.

    Article  PubMed  Google Scholar 

  22. Rubello D, Mazzarotto R, Casara D. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery. Eur J Nucl Med. 2000;27:431–40.

    Article  PubMed  CAS  Google Scholar 

  23. Campennì A, Violi MA, Ruggeri RM, et al. Clinical usefulness of 99mTc-MIBI scintigraphy in the postsurgical evaluation of patients with differentiated thyroid cancer. Nucl Med Commun. 2010;31:274–9.

    Article  PubMed  Google Scholar 

  24. Palestro CJ, Love C, Tronco GG, Tomas MB. Role of radionuclide imaging in the diagnosis of postoperative infection. Radiographics. 2000;20:1649–60.

    PubMed  CAS  Google Scholar 

  25. Krausz Y, Lebensart PD, Klein M, et al. Preoperative localization of parathyroid adenoma in patients with concomitant thyroid nodular disease. World J Surg. 2000;24:1573–8.

    Article  PubMed  CAS  Google Scholar 

  26. Rini JN, Leonidas JC, Tomas MB, Chen B, Karaylcin G, Palestro CJ. 18F-FDG uptake in the anterior mediastinum. Physiologic thymic uptake or disease? Clin Positron Imaging. 2000;3:115–25.

    Article  PubMed  Google Scholar 

  27. Malhi H, Annamaneni P, Slehria S, et al. Cyclophosphamide disrupts hepatic sinusoidal endothelium and improves transplanted cell engraftment in rat liver. Hepatology. 2002;36:112–21.

    Article  PubMed  CAS  Google Scholar 

  28. Gómez-Ramírez J, Sancho-Insenser JJ, Pereira JA, Jimeno J, Munné A, Sitges-Serra A. Impact of thyroid nodular disease on 99mTc-sestamibi scintigraphy in patients with primary hyperparathyroidism. Langenbecks Arch Surg. 2010;395:929–33.

    Article  PubMed  Google Scholar 

  29. Leslie WD, Dupont JO, Bybel B, Riese KT. Parathyroid 99mTc-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout. Eur J Nucl Med Mol Imaging. 2002;29:1566–70.

    Article  PubMed  Google Scholar 

  30. Mullan BP. Nuclear medicine imaging of the parathyroid. Otolaryngol Clin North Am. 2004;37:909–39, xi–xii.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Edwin O. Onkendi MBChB.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Onkendi, E.O., Richards, M.L., Thompson, G.B. et al. Thyroid Cancer Detection with Dual-isotope Parathyroid Scintigraphy in Primary Hyperparathyroidism. Ann Surg Oncol 19, 1446–1452 (2012). https://doi.org/10.1245/s10434-012-2282-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-012-2282-x

Keywords

Navigation